<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">AIDS Res Hum Retroviruses</journal-id><journal-id journal-id-type="iso-abbrev">AIDS Res. Hum. Retroviruses</journal-id><journal-id journal-id-type="publisher-id">aid</journal-id><journal-title-group><journal-title>AIDS Research and Human Retroviruses</journal-title></journal-title-group><issn pub-type="ppub">0889-2229</issn><issn pub-type="epub">1931-8405</issn><publisher><publisher-name>Mary Ann Liebert, Inc., publishers</publisher-name><publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7398440</article-id><article-id pub-id-type="pmid">32281388</article-id><article-id pub-id-type="publisher-id">10.1089/aid.2020.0031</article-id><article-id pub-id-type="doi">10.1089/aid.2020.0031</article-id><article-categories><subj-group subj-group-type="heading"><subject>Epidemiology</subject></subj-group></article-categories><title-group><article-title>New Genomes from the Congo Basin Expand History of CRF01_AE Origin and Dissemination</article-title><alt-title alt-title-type="left-running-head">Junqueira et al.</alt-title><alt-title alt-title-type="right-running-head">CRF01_AE Dissemination</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Junqueira</surname><given-names>Dennis Maletich</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wilkinson</surname><given-names>Eduan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vallari</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Xianding</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Achari</surname><given-names>Asmeeta</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Guixia</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>McArthur</surname><given-names>Carole</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kaptue</surname><given-names>Lazare</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mbanya</surname><given-names>Dora</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref><xref ref-type="aff" rid="aff10"><sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chiu</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff11"><sup>11</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cloherty</surname><given-names>Gavin A.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Tulio</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff12"><sup>12</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rodgers</surname><given-names>Mary A.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="corr1"/></contrib><aff id="aff1"><label><sup>1</sup></label>Centro Universit&#x000e1;rio Ritter dos Reis-UniRitter, Porto Alegre, Brazil.</aff><aff id="aff2"><label><sup>2</sup></label>KwaZulu-Natal Research Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, Republic of South Africa.</aff><aff id="aff3"><label><sup>3</sup></label>School of Laboratory Medicine and Medical Science, College of Health Sciences, University of KwaZulu-Natal, Durban, Republic of South Africa.</aff><aff id="aff4"><label><sup>4</sup></label>Abbott Diagnostics, Infectious Disease Research, Abbott Park, Illinois, USA.</aff><aff id="aff5"><label><sup>5</sup></label>Department of Laboratory Medicine, University of California, San Francisco, California, USA.</aff><aff id="aff6"><label><sup>6</sup></label>UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA.</aff><aff id="aff7"><label><sup>7</sup></label>School of Dentistry and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.</aff><aff id="aff8"><label><sup>8</sup></label>Universit&#x000e9; des Montagnes, Bangangt&#x000e9;, Cameroon.</aff><aff id="aff9"><label><sup>9</sup></label>Universit&#x000e9; de Yaound&#x000e9; I, Yaound&#x000e9;, Cameroon.</aff><aff id="aff10"><label><sup>10</sup></label>University of Bamenda, Bamenda, Cameroon.</aff><aff id="aff11"><label><sup>11</sup></label>Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, California, USA.</aff><aff id="aff12"><label><sup>12</sup></label>Research Department of Infection, University College London, London, United Kingdom.</aff></contrib-group><author-notes><corresp id="corr1">Address correspondence to: Mary A. Rodgers, Abbott Diagnostics, Infectious Disease Research, 100 Abbott Park Road, Abbott Park, IL 60064-6400, USA <email>mary.rodgers@abbott.com</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>7</month><year>2020</year><string-date>July 2020</string-date></pub-date><pub-date pub-type="epub"><day>02</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>02</day><month>7</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>36</volume><issue>7</issue><fpage>574</fpage><lpage>582</lpage><permissions><copyright-statement>&#x000a9; Dennis Maletich Junqueira, et al. 2020; Published by Mary Ann Liebert, Inc.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Dennis Maletich Junqueira, et al. </copyright-holder><license license-type="open-access"><license-p>This Open Access article is distributed under the terms of the Creative Commons License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="aid.2020.0031.pdf"/><abstract><p>Although the first HIV circulating recombinant form (CRF01_AE) is the predominant strain in many Asian countries, it is uncommonly found in the Congo Basin from where it first originated. To fill the gap in the evolutionary history of this important strain, we sequenced near complete genomes from HIV samples with subgenomic CRF01_AE regions collected in Cameroon and the Democratic Republic of the Congo from 2001 to 2006. HIV genomes were generated from <italic>N</italic>&#x02009;=&#x02009;13 plasma specimens by next-generation sequencing of metagenomic libraries prepared with spiked primers targeting HIV, followed by Sanger gap-filling. Genome sequences were aligned to reference strains, including Asian and African CRF01_AE sequences, and evaluated by phylogenetic and recombinant analysis to identify four CRF01_AE strains from Cameroon. We also identified two CRF02, one CRF27, and six unique recombinant form genomes (01|A1|G, 01|02|F|U, F|G|01, A1|D|01, F|G|01, and A1|G|01). Phylogenetic analysis, including the four new African CRF01_AE genomes, placed these samples as a bridge between basal Central African Republic CRF01_AE strains and all Asian, European, and American CRF01_AE strains. Molecular dating confirmed previous estimates indicating that the most recent common CRF01_AE ancestor emerged in the early 1970s (1968&#x02013;1970) and spread beyond Africa around 1980 to Asia. The new sequences and analysis presented in this study expand the molecular history of the CRF01_AE clade, and are illustrated in an interactive Next Strain phylogenetic tree, map, and timeline at (<uri xlink:href="https://nextstrain.org/community/EduanWilkinson/hiv-1_crf01">https://nextstrain.org/community/EduanWilkinson/hiv-1_crf01</uri>).</p></abstract><kwd-group kwd-group-type="author"><kwd>HIV</kwd><kwd>CRF</kwd><kwd>surveillance</kwd><kwd>Congo</kwd><kwd>phylogenetics</kwd><kwd>molecular clock analysis</kwd></kwd-group><counts><fig-count count="4"/><table-count count="1"/><ref-count count="49"/><page-count count="9"/></counts></article-meta></front><body><sec sec-type="intro" id="s001"><title>Introduction</title><p>CRF01<sc>_AE was the first</sc> circulating recombinant form (CRF) to be identified in the HIV type 1 (HIV-1) epidemic.<sup><xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref></sup> The genome structure of this virus appeared to be a mosaic strain containing a mixture of subtype A and portions of sequences that did not cluster with other known subtypes of HIV-1 at the time. The non-A regions (portions of <italic>vif</italic>, <italic>vpr</italic>, <italic>env</italic>, <italic>nef</italic>, and 3&#x02032; long terminal repeat) were classified as subtype E, although a complete subtype E genome has not been identified to date. The earliest isolates of CRF01_AE were collected in 1990 in the Central African Republic (CAR).<sup><xref rid="B2" ref-type="bibr">2&#x02013;4</xref></sup> Molecular characterization of the envelope region from strains circulating in Africa in the 1990s indicated that genotype E accounted for 31% of 29 randomly selected samples collected in CAR,<sup><xref rid="B4" ref-type="bibr">4</xref></sup> whereas subtype E was absent from studies conducted in Uganda, Zaire (now Democratic Republic of the Congo [DRC]), Malawi, and Tanzania.<sup><xref rid="B5" ref-type="bibr">5&#x02013;8</xref></sup></p><p>In contrast, HIV isolates collected from Thailand in the 1990s were dominated by subtype E envelope sequences.<sup><xref rid="B9" ref-type="bibr">9</xref></sup> Once this &#x0201c;subtype&#x0201d; was officially recognized as CRF01_AE in the late 1990s, many molecular epidemiological surveys confirmed that CRF01_AE has continued to predominate the epidemics in Southeast Asia over the past three decades (reaching up to almost 82% among HIV-1 infections in the region).<sup><xref rid="B10" ref-type="bibr">10</xref></sup> The spread of CRF01_AE has been tracked from Thailand to Vietnam, China, and ultimately a global dissemination.<sup><xref rid="B11" ref-type="bibr">11&#x02013;14</xref></sup> However, CRF01_AE has not extensively spread within Central Africa, with CRF01_AE infection having a prevalence of &#x0003c;1% in nearby Cameroon,<sup><xref rid="B15" ref-type="bibr">15</xref></sup> &#x0003c;4% in DRC,<sup><xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref></sup> &#x0003c;3% in Chad,<sup><xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref></sup> &#x0003c;1% in the Republic of the Congo,<sup><xref rid="B20" ref-type="bibr">20&#x02013;22</xref></sup> and 6% in CAR<sup><xref rid="B23" ref-type="bibr">23</xref></sup> in recent studies. However, the extent to which CRF01_AE may still be circulating within recombinant strains cannot be evaluated with subgenomic sequences reported in most of these studies.</p><p>Both subgenomic sequences and complete genomes have been used to estimate when CRF01_AE first emerged in Africa and became a key Asian strain. Bayesian analysis with subgenomic sequences estimated the origins of CRF01_AE in Central Africa to the 1960s by several models.<sup><xref rid="B14" ref-type="bibr">14</xref></sup> More recently, analyses with four complete genome sequences have estimated that CRF01_AE first emerged in CAR in the 1970s and was introduced in Asia in the early 1980s (Ref.<sup><xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref></sup>). The evolutionary path of CRF01_AE between CAR and Asia has not been well characterized due to the limited number of only four CRF01_AE complete genome sequences ever produced from Africa, which could be a reflection of its low prevalence.</p><p>To address this gap, near-complete genome sequences were generated from <italic>N</italic>&#x02009;=&#x02009;13 specimens collected in Cameroon and DRC carrying HIV strains identified as CRF01_AE by next-generation sequencing (NGS) and subgenomic Sanger sequencing. Phylogenetic analysis with references from CAR and Asia indicates that four new Cameroonian CRF01_AE strains sequenced herein provide a new molecular link between the two previously well-characterized major clades.</p></sec><sec sec-type="materials|methods" id="s002"><title>Materials and Methods</title><sec id="s003"><title>Study subjects</title><p>Thirteen plasma specimens were collected between 2001 and 2006 from HIV-1-positive individuals participating in viral diversity studies in Cameroon and the DRC (<xref rid="tb1" ref-type="table">Table 1</xref>). The specimens came from blood donors or participants seeking voluntary testing as previously described.<sup><xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B24" ref-type="bibr">24</xref></sup> The DRC study was approved by the University of Missouri-Kansas City Research Board. The Cameroon study was approved by the Cameroon National Ethical Review Board, the Faculty of Medicine and Biomedical Science Institutional Review Boards (IRB), and the Ministry of Health of Cameroon.</p><table-wrap id="tb1" orientation="landscape" position="float"><label>Table 1.</label><caption><p>Sample Origin and Recombination Analysis Summary of Thirteen HIV-1 Sequences Isolated in Africa </p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th rowspan="2" align="left" valign="bottom">Sample ID</th><th rowspan="2" align="center" valign="bottom">Year</th><th rowspan="2" align="center" valign="bottom">Country</th><th rowspan="2" align="center" valign="bottom">Viral load (log copies/mL)</th><th colspan="2" align="center" valign="bottom">REGA<hr/></th><th rowspan="2" align="center" valign="bottom">jpHMM</th><th rowspan="2" align="center" valign="bottom">Simplot</th><th colspan="2" align="center" valign="bottom">BLAST<hr/></th><th rowspan="2" align="center" valign="bottom">RAxML</th><th rowspan="2" align="center" valign="bottom">Final</th></tr><tr><th align="center" valign="bottom">Classification</th><th align="center" valign="bottom">Bootstrap strength</th><th align="center" valign="bottom">Classification</th><th align="center" valign="bottom">Identity</th></tr></thead><tbody><tr><td align="left" valign="bottom">260-27</td><td align="center" valign="bottom">2005</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">5.32</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">A1/G/01/U</td><td align="left" valign="bottom">01/G/A</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">90%</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">URF_A1/G/01</td></tr><tr><td align="left" valign="bottom">890-05</td><td align="center" valign="bottom">2006</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">5.05</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">A1/G</td><td align="left" valign="bottom">A1/G</td><td align="left" valign="bottom">CRF02_AG</td><td align="center" valign="bottom">93%</td><td align="left" valign="bottom">CRF02_AG</td><td align="left" valign="bottom">CRF02_AG</td></tr><tr><td align="left" valign="bottom">A1188</td><td align="center" valign="bottom">2002</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">4.25</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">CRF01/A1/G</td><td align="left" valign="bottom">CRF01/A1/G</td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">92%</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">URF_01/A1/G</td></tr><tr><td align="left" valign="bottom">A1152</td><td align="center" valign="bottom">2002</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">4.22</td><td align="left" valign="bottom">CRF02_AG</td><td align="center" valign="bottom">100</td><td align="left" valign="bottom">A1/G</td><td align="left" valign="bottom">A1/G</td><td align="left" valign="bottom">CRF02_AG</td><td align="center" valign="bottom">93%</td><td align="left" valign="bottom">CRF02_AG</td><td align="left" valign="bottom">CRF02_AG</td></tr><tr><td align="left" valign="bottom">A1549</td><td align="center" valign="bottom">2002</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">4.11</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">A1/G/F2/01</td><td align="left" valign="bottom">CRF01/A1/F/G/U</td><td align="left" valign="bottom">URF_0222</td><td align="center" valign="bottom">89%</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">URF_01/02/F/U</td></tr><tr><td align="left" valign="bottom">CG-0422-02V</td><td align="center" valign="bottom">2002</td><td align="left" valign="bottom">DRC</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">A1/D/01</td><td align="left" valign="bottom">A1/D/01</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">90%</td><td align="left" valign="bottom">D</td><td align="left" valign="bottom">URF_A1/D/01</td></tr><tr><td align="left" valign="bottom">CG-0427a-02V</td><td align="center" valign="bottom">2002</td><td align="left" valign="bottom">DRC</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">F1/G/01/U</td><td align="left" valign="bottom">F/G/01</td><td align="left" valign="bottom">F1</td><td align="center" valign="bottom">90%</td><td align="left" valign="bottom">F1</td><td align="left" valign="bottom">URF_F/G/01</td></tr><tr><td align="left" valign="bottom">CG-0070-01</td><td align="center" valign="bottom">2001</td><td align="left" valign="bottom">DRC</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">F1/G/01/U</td><td align="left" valign="bottom">F/G/01</td><td align="left" valign="bottom">F1</td><td align="center" valign="bottom">89%</td><td align="left" valign="bottom">F1</td><td align="left" valign="bottom">URF_F/G/01</td></tr><tr><td align="left" valign="bottom">CG-0077-01</td><td align="center" valign="bottom">2003</td><td align="left" valign="bottom">DRC</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">CRF27_cpx</td><td align="center" valign="bottom">100</td><td align="left" valign="bottom">G/H/C/J/01/A1/B</td><td align="left" valign="bottom">G/H/J/C/01/A1</td><td align="left" valign="bottom">CRF27_cpx</td><td align="center" valign="bottom">90%</td><td align="left" valign="bottom">CRF27_cpx</td><td align="left" valign="bottom">CRF27_cpx</td></tr><tr><td align="left" valign="bottom">U7957</td><td align="center" valign="bottom">2003</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">100</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">CRF01_AE<sup><xref ref-type="table-fn" rid="tf1">a</xref></sup></td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">92%</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">CRF01_AE</td></tr><tr><td align="left" valign="bottom">U8216</td><td align="center" valign="bottom">2003</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">NA</td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">100</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">CRF01_AE<sup><xref ref-type="table-fn" rid="tf1">a</xref></sup></td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">93%</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">CRF01_AE</td></tr><tr><td align="left" valign="bottom">234-40</td><td align="center" valign="bottom">2005</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">4.14</td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">100</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">CRF01_AE<sup><xref ref-type="table-fn" rid="tf1">a</xref></sup></td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">92%</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">CRF01_AE</td></tr><tr><td align="left" valign="bottom">1002-28</td><td align="center" valign="bottom">2006</td><td align="left" valign="bottom">CM</td><td align="center" valign="bottom">4.81</td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">100</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">CRF01_AE<sup><xref ref-type="table-fn" rid="tf1">a</xref></sup></td><td align="left" valign="bottom">CRF01_AE</td><td align="center" valign="bottom">92%</td><td align="left" valign="bottom">CRF01_AE</td><td align="left" valign="bottom">CRF01_AE</td></tr></tbody></table><table-wrap-foot><fn id="tf1"><label><sup>a</sup></label><p>Reference sequences for the Simplot analyses are described in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S2</xref>.</p></fn><fn id="tf2"><p>01, CRF01_AE; BLAST, Basic Local Alignment Search Tool; CM, Cameroon; CRF, circulating recombinant form; DRC, Democratic Republic of the Congo; jpHMM, jumping profile Hidden Markov Model; NA, not assigned; RAxML, Randomized Axelerated Maximum Likelihood; REGA, software from Rega Institute in Central Belgium; URF, unique recombinant form.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s004"><title>Amplification and sequencing</title><p>All near full-length nucleotide sequences of HIV-1 (HXB2: 94-9720) were amplified and sequenced from plasma viral RNA by a metagenomic sequencing with spiked primer enrichment (MSSPE) NGS approach.<sup><xref rid="B25" ref-type="bibr">25</xref></sup> Gaps were filled in by supplemental Sanger sequencing.<sup><xref rid="B16" ref-type="bibr">16</xref></sup> Briefly, nucleic acid was extracted from plasma according to the manufacturers' instructions using (i) the EZ1 Advanced XL system and EZ1 Virus Mini Kit (Qiagen, Hilden, Germany) for NGS or (ii) the RNA extraction protocol on an m2000sp system (Abbott Molecular, Des Plaines, IL) for Sanger sequencing. For NGS, random hexamer (RH) primers (Life Technologies) were spiked with HIV-specific primers.<sup><xref rid="B25" ref-type="bibr">25</xref></sup> These primers were designed from 3,571 reference genomes, which cover genotypes M, N, O, and P of HIV-1 (<xref ref-type="supplementary-material" rid="SD2">Supplementary Table S1</xref>). A total of 798 primers of 13 nucleotides (464 forward and 334 reverse) were ordered and synthesized by Integrated DNA Technologies, Inc. (IDT, Coralville, IA). The HIV RNA extract was mixed with spiked primer (4&#x02009;&#x003bc;M) plus RH (0.4&#x02009;&#x003bc;M) in a 10:1 ratio and heated to 65&#x000b0;C for 5&#x02009;min. The reverse transcription master mix (10&#x02009;mL SuperScript III buffer, 5&#x02009;mL dNTP of 12.5&#x02009;mM, 2.5&#x02009;mL DTT of 0.1&#x02009;M, and 1&#x02009;mL SuperScript III enzyme) was added to each sample and incubated at 25&#x000b0;C for 5&#x02009;min, followed by 42&#x000b0;C for 30&#x02009;min and 94&#x000b0;C for 2&#x02009;min. Generated complementary DNA went through metagenomic library preparation using Illumina Nextera XT protocol to be analyzed on a HiSeq instrument (Illumina). Genome consensus sequences were generated using CLC Bio and Sanger sequences covering gaps were merged into the consensus using Sequencher v5.4.1 (Genecodes) as previously described.<sup><xref rid="B16" ref-type="bibr">16</xref></sup> All open reading frames were annotated with SeqBuilder (DNAStar Laservene, v15) software. The Genbank accession numbers for the 13 HIV-1 genomes are MN116200-MN116212.</p></sec><sec id="s005"><title>Recombination analysis and sequence data</title><p>Recombination structures of all thirteen genomes were determined by five different detection methods: (i) REGA subtyping tool v3.0 (Ref.<sup><xref rid="B26" ref-type="bibr">26</xref></sup>); (ii) jumping profile Hidden Markov Model (jpHMM)-HIV<sup><xref rid="B27" ref-type="bibr">27</xref></sup>; (iii) Simplot v3.5.1 (Ref.<sup><xref rid="B28" ref-type="bibr">28</xref></sup>) under the Kimura 2-parameter model and a sliding window of 200 nucleotides increased by increments of 20 nucleotides; (iv) nucleotide Basic Local Alignment Search Tool (BLAST) to search for the most similar sequences; and (v) through phylogenetic reconstruction against a comprehensive dataset of 500 HIV-1 whole-genome sequences<sup><xref rid="B16" ref-type="bibr">16</xref></sup> or through. The whole-genome phylogenetic reconstruction was performed in Randomized Axelerated Maximum Likelihood (RAxML)<sup><xref rid="B29" ref-type="bibr">29</xref></sup> incorporating the best-fitting model of nucleotide substitution as determined in important quartets (IQ)-Tree<sup><xref rid="B30" ref-type="bibr">30</xref></sup> and 1,000 bootstrap replicates<sup><xref rid="B31" ref-type="bibr">31</xref></sup> that were used to infer transfer support for branches in the phylogeny.<sup><xref rid="B32" ref-type="bibr">32</xref></sup> The final genome classification was defined based on the results of all five methods.</p></sec><sec id="s006"><title>Phylogenetic and phylogeographic reconstruction</title><p>Isolates identified as CRF01_AE in this study were analyzed against all whole-genome CRF01_AE sequences in the Los Alamos National Laboratory (LANL) HIV-1 sequence database (<italic>n</italic>&#x02009;=&#x02009;382; accessed October 2018). First, we re-subtyped these reference sequences with REGA v3.0 (Ref.<sup><xref rid="B26" ref-type="bibr">26</xref></sup>) and jpHMM<sup><xref rid="B27" ref-type="bibr">27</xref></sup> to insure the correct subtype assignment. Sequences presenting classification discrepancies from the Genbank information were excluded from the dataset (<italic>n</italic>&#x02009;=&#x02009;11).</p><p>The final dataset was submitted to a Nextstrain build.<sup><xref rid="B33" ref-type="bibr">33</xref></sup> Nextstrain consists of a suite of tools that take raw sequences (in fasta format) and associated metadata (e.g., time, country, publications, authors, and/or journals) as input. In short, Nextstrain performs a sequence alignment of the input data in multiple sequence alignment based on Fast Fourier transform (MAFFT),<sup><xref rid="B34" ref-type="bibr">34</xref></sup> which in turn is used to infer a maximum likelihood. For the purpose of this study, the maximum likelihood (ML) tree topology was inferred in RAxML using the general time-reversible (GTR)+G+I model of nucleotide substitution.<sup><xref rid="B35" ref-type="bibr">35</xref></sup> The resulting tree topology is then transformed into a dated phylogeny where the branches correspond to units of real calendar time using a least squared dating approach.<sup><xref rid="B36" ref-type="bibr">36</xref></sup> In turn, the dated phylogeny is used to perform ancestral state reconstruction to infer the probable location of internal nodes in the phylogeny using a marginal likelihood approach. Finally, the time-scaled tree and the spatial reconstruction are then visualized together in a web browser with auspice.<sup><xref rid="B33" ref-type="bibr">33</xref></sup></p></sec><sec id="s007"><title>Phylodynamic reconstruction</title><p>Demographic history of the CRF01_AE epidemic was examined under a Bayesian Markov Chain Monte Carlo approach as implemented in BEAST v.1.8.4 (Ref.<sup><xref rid="B37" ref-type="bibr">37</xref></sup>). First, a phylogenetic tree of the CRF01_AE whole-genome sequences (<italic>n</italic>&#x02009;=&#x02009;4) was aligned with 371 whole-genome CRF01_AE reference sequences from LANL in MAFFT v7.0 (Ref.<sup><xref rid="B34" ref-type="bibr">34</xref></sup>). The subsequent alignment was used to construct an ML tree topology in RAxML v8.0 under the GTR+G+I model of nucleotide substitution and 1,000 bootstrap replicates. The resulting phylogeny was manually inspected in FigTree<sup><xref rid="B38" ref-type="bibr">38</xref></sup> and highly monophyletic clades&#x02014;defined as containing three or more sequences from the same country and with good branch support (&#x0003e;0.95)&#x02014;were pruned with the ape package in R<sup><xref rid="B39" ref-type="bibr">39</xref></sup> to only one sequence, preferably keeping the oldest isolate in the clade. The pruned phylogeny (<italic>N</italic>&#x02009;=&#x02009;179) was tested for good clock-like signal in Tempest v1.5.1 using the sampling dates and root-to-tip divergence.<sup><xref rid="B40" ref-type="bibr">40</xref></sup> An additional 61 sequences were removed as outliers resulting in a final R<sup>2</sup> of 0.903 and a slope rate of &#x0223c;3.22&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> mutations per site per year, and with an <italic>x</italic>-intercept around 1969.7 (<xref ref-type="supplementary-material" rid="SD3">Supplementary Fig. S1</xref>).</p><p>This dataset was submitted to a Bayesian analysis incorporating the best-fitted nucleotide substitution model (GTR +4&#x00393;+I+F) as determined in IQ-Tree<sup><xref rid="B41" ref-type="bibr">41</xref></sup> with an uncorrelated lognormal relaxed molecular clock<sup><xref rid="B42" ref-type="bibr">42</xref></sup> and various coalescent tree priors (e.g., skyride, skygrid, and skyline, constant and exponential growth). Bayes factor comparison between various coalescent tree priors consistently favored the use of the skyride coalescent tree prior.<sup><xref rid="B43" ref-type="bibr">43</xref></sup> The molecular clock was calibrated using the sampling dates of the sequences under a uniform-distributed prior for the evolutionary rate according to previous simulations. After 5&#x02009;&#x000d7;&#x02009;10<sup>8</sup> steps, convergence was checked using Tracer v1.6 discarding the first 50% of values for burn-in.<sup><xref rid="B44" ref-type="bibr">44</xref></sup> Following the discarding of the burn-in, the remaining posterior parameters and trees were used to reconstruct the demographic growth of the global HIV-1 CRF01_AE linage through time.</p></sec></sec><sec sec-type="results" id="s008"><title>Results</title><sec id="s009"><title>Sequence generation</title><p>A set of <italic>N</italic>&#x02009;=&#x02009;13 specimens with subgenomic sequences classified as CRF01 was identified from previous viral diversity studies conducted in Cameroon and DRC for complete genome sequencing. A range of 4.11&#x02013;5.32 log copies/ml HIV RNA was detected among samples with previous viral load results available (<italic>N</italic>&#x02009;=&#x02009;7). NGS of all 13 samples using the MSSPE method yielded complete or near-complete genomes of at least 8,800 nucleotides in length. Full coverage was achieved for <italic>N</italic>&#x02009;=&#x02009;8 samples and &#x0003e;90% coverage for <italic>N</italic>&#x02009;=&#x02009;5 (A1549, 1002-28, 234-40, A1152, and A1188), which were filled in further by Sanger sequencing. Average read depths for each genome ranged from 14 to 18,899&#x02009;&#x000d7;&#x02009;and the number of reads mapping to the consensus ranged from 1,060 to 1,744,672.</p></sec><sec id="s010"><title>Recombination analysis</title><p>Genome-wide recombination analyses of whole-genome sequences were performed to determine the viral subtype and to detect evidence of intersubtype recombination. Despite minor differences, all five methods we employed to characterize the genome profiles of the whole-genome sequences broadly led to similar results (<xref rid="tb1" ref-type="table">Table 1</xref>). Based on consensus agreement between the five different methods, we identified four CRF01_AE isolates (U7957, U8216, 234-40, and 1002-28) and six unique recombinant forms (260-27, A1188, A1549, CG-0422-02V, CG-0427a-02V, and CG-0070-01) that included portions of genomic regions assigned to CRF01_AE (<xref ref-type="fig" rid="f1">Fig. 1</xref>). Of the remaining three whole-genome sequences, two were classified as CRF02_AG (890-05 and A1152) and one as belonging to CRF27_cpx (CG-0077-01).</p><fig id="f1" fig-type="figure" orientation="portrait" position="float"><label>FIG. 1.</label><caption><p>Schematic representation of jpHMM recombination results for thirteen HIV samples collected between 2001 and 2006 from HIV-1-positive individuals in Cameroon and the DRC samples isolated in the Congo Basin, Africa. Viral subtypes were denoted by <italic>different colors</italic> according to the legend. The <italic>gray</italic> N/A portions correspond to unclassifiable regions. CRF, circulating recombinant form; DRC, Democratic Republic of the Congo; jpHMM, jumping profile Hidden Markov Model; LTR, long terminal repeat; N/A, not assigned.</p></caption><graphic xlink:href="aid.2020.0031_figure1"/></fig></sec><sec id="s011"><title>Phylogenetic and phylogeographic reconstruction</title><p>Only CRF01_AE sequences were submitted to further phylogenetic analysis. The four CRF01_AE strains isolated in this study were aligned to 371 CRF01_AE sequences from LANL, after a filtering step to achieve a more equitable temporal and geographic distribution as implemented in Nextstrain (final alignment; <italic>n</italic>&#x02009;=&#x02009;358). Our phylogenetic and evolutionary analysis of near full-length CRF01_AE sequences in Nextstrain indicates that HIV-1 CRF01_AE arose in Africa in the early 1970s (1968&#x02013;1970) (<xref ref-type="fig" rid="f2">Figs. 2</xref>&#x02013;<xref ref-type="fig" rid="f4">4</xref>). As expected, our isolates grouped at the base of the tree with four other samples from Central Africa (three from the CAR and one from Cameroon) (<xref ref-type="fig" rid="f2">Fig. 2</xref>). This pattern suggests that Cameroon has a secondary role in the African CRF01_AE epidemic and was seeded by Central African viruses around 1974 (1973&#x02013;1975). The grouping of the four sequences in the base of the tree suggests that the current epidemic in Africa was directly derived from the primary CRF01_AE strains. The estimated evolutionary rate for this dataset was 1.5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> nucleotide substitutions/site/year.</p><fig id="f2" fig-type="figure" orientation="portrait" position="float"><label>FIG. 2.</label><caption><p>Nextstrain maximum-likelihood phylogenetic analysis of CRF01_AE whole-genome sequences. Tree branches are colored according to sampling origin. The sequences described in this study are located at the base of the tree identified by a <italic>red contour</italic>.</p></caption><graphic xlink:href="aid.2020.0031_figure2"/></fig><p>After almost 10 years of localized transmissions, the first divergence from the African strains was estimated to have occurred in the early 1980s (1980&#x02013;1981) by the introduction of the virus in Thailand. It seems that only one or a few strains were imported from Africa and reached Asia. Thai sequences were found to be dispersed throughout the tree, structuring the basal positions to several clusters (<xref ref-type="fig" rid="f2">Fig. 2</xref>). This pattern suggests that this lineage is likely to be the ancestor of all CRF01_AE strains in Asia (<xref ref-type="fig" rid="f4">Fig. 4</xref>). Specifically, Thai sequences seeded the epidemics in China, Myanmar, the Philippines, Indonesia, the United States, The United Kingdom, and Sweden (<xref ref-type="fig" rid="f4">Fig. 4</xref>). The epidemic in China that started in 1984 was driven by multiple independent lineages, most of them imported from Thailand. Thai sequences fall within the base of four major Chinese clusters and point to independent introductions of this strain into China. The Chinese epidemic was also seeded by strains from Vietnam in the mid-1990s (<xref ref-type="fig" rid="f2">Fig. 2</xref>). In addition, Chinese sequences were also found dispersed throughout the tree lying next to Thai sequences indicating extensive interaction between the two epidemics. The evolutionary history of the CRF01_AE strains as they exited Africa and were introduced to Asia, Europe, and the Americas is illustrated in an interactive phylogenetic tree, map, and timeline at <uri xlink:href="https://nextstrain.org/community/EduanWilkinson/hiv-1_crf01">https://nextstrain.org/community/EduanWilkinson/hiv-1_crf01</uri>.</p></sec><sec id="s012"><title>Phylodynamics of CRF01_AE</title><p>We further investigated the past population dynamics of CRF01_AE using 179 sequences under a Bayesian skyride model (<xref ref-type="fig" rid="f3">Fig. 3</xref>). Consistent with the ML results, we estimated the time of the most recent common ancestor of CRF01_AE to be around 1971 (95% highest posterior density (HPD): 1970&#x02013;1973) (<xref ref-type="supplementary-material" rid="SD4">Supplementary Fig. S2</xref>). The estimate of the effective number of HIV-1 infections through time shows an exponential increase in the viral population between 1971 and 1980, period in which the virus was still circulating in Africa (<xref ref-type="fig" rid="f4">Fig. 4</xref>). The introduction of CRF01_AE in Asian countries is followed by a short decrease in the CRF01_AE population probably due to the unsustained number of dead-end infections (<xref ref-type="fig" rid="f3">Figs. 3</xref> and <xref ref-type="fig" rid="f4">4</xref>). After 1985, the number of new CRF01_AE infections exponentially increases, reaching a plateau after the 2000s. More recently, we observed a decrease in these estimates; however, the 95% Bayesian confidence interval prevents us to confirming this hypothesis.</p><fig id="f3" fig-type="figure" orientation="portrait" position="float"><label>FIG. 3.</label><caption><p>Temporal dynamics of CRF01_AE spread from Africa. Bayesian skygrid estimates of past population dynamics for CRF01_AE were plotted. The <italic>left y</italic>-axis represents the effective number of infections (Ne) and the <italic>x</italic>-axis the time.</p></caption><graphic xlink:href="aid.2020.0031_figure3"/></fig><fig id="f4" fig-type="figure" orientation="portrait" position="float"><label>FIG. 4.</label><caption><p>Nextstrain geographical view of CRF01_AE temporal dynamics. The geographical locations of isolates at each snapshot in time on the Bayesian skygrid are depicted with links between related strains indicated by a line. Lines between countries represent putative HIV transitions between regions and circle diameters are proportional to the square root of the number of branches that maintain the same location state at each time-point. Estimates of past population dynamics for CRF01_AE are plotted on the maps from <bold>A</bold> to <bold>F</bold>.</p></caption><graphic xlink:href="aid.2020.0031_figure4"/></fig></sec></sec><sec sec-type="discussion" id="s013"><title>Discussion</title><p>The four African CRF01_AE genomes presented in this study provide further resolution for the epidemiology of the CRF01_AE clade and provide a new genetic link between the African and Asian CRF01_AE clades of the HIV-1 pandemic. First, phylogenetic analysis with the new Cameroonian CRF01_AE strains confirmed the African origin of CRF01_AE.<sup><xref rid="B12" ref-type="bibr">12&#x02013;14</xref></sup> Likewise, molecular dating with these strains was consistent with previous estimates of emergence of CRF01_AE in Africa in the early 1970s and in Asia in the early 1980s (Refs.<sup><xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref></sup>). CRF01_AE appears to have originated in CAR where it spread to Cameroon and other countries in central Africa, although limited sampling from African countries prevents further resolution of the spread of CRF01_AE in the region. After &#x0223c;10 years of localized transmission in central Africa, CRF01_AE spread to Thailand and onward to other Asian countries (<xref ref-type="fig" rid="f4">Fig. 4</xref>). These results suggest a scenario of multiple introductions into epidemiologically linked, high-risk groups, primarily heterosexual, people who inject drugs and man who have sex with man related clusters.</p><p>The four CRF01_AE genomes from Cameroon were identified among a larger set of <italic>N</italic>&#x02009;=&#x02009;13 genomes that were previously classified as CRF01_AE based on sequencing of smaller subgenomic regions. However, the detection of recombination in the majority of these strains (<italic>N</italic>&#x02009;=&#x02009;9) highlights the limitations of subgenomic sequences for classifying strains. Surprisingly, three recombinant genomes were identified among these that were classified as CRF02_AG or CRF27_cpx (<xref rid="tb1" ref-type="table">Table 1</xref>). This finding is likely explained by similarities in the regions found in both CRF01_AE and CRF01_AG, as well as the presence of CRF01_AE in the complex recombinant pattern of CRF27_cpx.<sup><xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B45" ref-type="bibr">45</xref>,<xref rid="B46" ref-type="bibr">46</xref></sup> These unexpected classifications confirm that full-length sequences provide the most accurate classification. Furthermore, the identification of mostly recombinant genomes in this dataset indicates that reliance upon subgenomic sequences alone can lead to underestimation of the amount of HIV recombination in a population. This is especially relevant for estimating the true prevalence of CRF01_AE, which could be skewed by subgenomic sequences from unrecognized recombinant genomes. Although CRF01_AE is rare in the Congo Basin, it is likely that its prevalence is actually much lower than has been estimated due to subgenomic sequence limitations. Interestingly, CRF01_AE has recently been found at dramatically higher rates in Kenya in 2008 and 2015 (14%&#x02013;25%),<sup><xref rid="B47" ref-type="bibr">47</xref>,<xref rid="B48" ref-type="bibr">48</xref></sup> although with subgenomic sequence classifications. Whether these strains represent a resurgence of CRF01_AE or a CRF01_AE-containing recombinant in East Africa remains to be seen.</p><p>The phylodynamic reconstruction with a skyride tree prior and the addition of more African sequences led to a more refined demographic reconstruction of this HIV-1 clade. The reconstruction suggests a small decrease in the effective population size in the early 1980s with another dip in the mid 1990s. The first followed the transmission from Africa to Asia and may relate to this migration event, while the second dip in the effective population size may very well be due to behavioral changes in Thailand at the outbreak of the epidemic in that country.<sup><xref rid="B49" ref-type="bibr">49</xref></sup></p><p>We anticipate that further sampling and sequencing of global CRF01_AE strains will provide additional resolution for the molecular and geographical epidemiology presented herein. To accommodate these future updates, the interactive CRF01_AE Next Strain phylogenetic tree, map, and timeline provide an ongoing resource for tracking this HIV clade. As more strains are sequenced, they can easily be merged with the CRF01_AE Next Strain dataset to enable comprehensive monitoring of this clade in real time.</p></sec><sec id="s014"><title>Sequence Data</title><p>The Genbank accession numbers for the 13 HIV-1 genomes are MN116200&#x02013;MN116212.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="Supp_Table2.pdf" orientation="portrait" id="d40e1292" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="docx" xlink:href="Supp_Table1.docx" orientation="portrait" id="d40e1297" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="Supp_Fig1.pdf" orientation="portrait" id="d40e1302" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="Supp_Fig2.pdf" orientation="portrait" id="d40e1307" position="anchor"/></supplementary-material></sec></body><back><sec id="s015" sec-type="COI-statement"><title>Author Disclosure Statement</title><p>No competing financial interests exist.</p></sec><sec id="s016"><title>Funding Information</title><p>This study was funded by Abbott Laboratories, IH grant R33-AI129455 (CYC) from the National Institute of Allergy and Infectious Diseases, NIH grant R01-HL105704 (CYC) from the National Heart, Lung, and Blood Institute, and the Charles and Helen Schwab Foundation (CYC).</p></sec><sec id="s017"><title>Supplementary Material</title><p><xref ref-type="supplementary-material" rid="SD3">Supplementary Figure S1</xref></p><p><xref ref-type="supplementary-material" rid="SD4">Supplementary Figure S2</xref></p><p><xref ref-type="supplementary-material" rid="SD2">Supplementary Table S1</xref></p><p><xref ref-type="supplementary-material" rid="SD1">Supplementary Table S2</xref></p></sec><ref-list content-type="parsed"><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Carr</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Salminen</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>C</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand</article-title>. <source>J Virol</source>
<year>1996</year>;<volume>70</volume>:<fpage>5935</fpage>&#x02013;<lpage>5943</lpage><pub-id pub-id-type="pmid">8709215</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>SG</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin</article-title>. <source>J Virol</source>
<year>1996</year>;<volume>70</volume>:<fpage>7013</fpage>&#x02013;<lpage>7029</lpage><pub-id pub-id-type="pmid">8794346</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Rodrigo</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Learn</surname><given-names>GH</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E</article-title>. <source>J Virol</source>
<year>2000</year>;<volume>74</volume>:<fpage>10752</fpage>&#x02013;<lpage>10765</lpage><pub-id pub-id-type="pmid">11044120</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Korber</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Georges-Courbot</surname><given-names>MC</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>1993</year>;<volume>9</volume>:<fpage>997</fpage>&#x02013;<lpage>1006</lpage><pub-id pub-id-type="pmid">8280481</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Albert</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Franzen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jansson</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>: <article-title>Ugandan HIV-1 V3 loop sequences closely related to the U.S./European consensus</article-title>. <source>Virology</source>
<year>1992</year>;<volume>190</volume>:<fpage>674</fpage>&#x02013;<lpage>681</lpage><pub-id pub-id-type="pmid">1519357</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Oram</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Downing</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Roff</surname><given-names>M</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Sequence analysis of the V3 loop regions of the env genes of Ugandan human immunodeficiency proviruses</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>1991</year>;<volume>7</volume>:<fpage>605</fpage>&#x02013;<lpage>614</lpage><pub-id pub-id-type="pmid">1768462</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Orloff</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Kalish</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Chiphangwi</surname><given-names>J</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>1993</year>;<volume>9</volume>:<fpage>705</fpage>&#x02013;<lpage>706</lpage><pub-id pub-id-type="pmid">8369176</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zwart</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wolfs</surname><given-names>TF</given-names></name>, <name name-style="western"><surname>Bookelman</surname><given-names>R</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: Serological and genetic analysis</article-title>. <source>AIDS</source>
<year>1993</year>;<volume>7</volume>:<fpage>467</fpage>&#x02013;<lpage>474</lpage><pub-id pub-id-type="pmid">8507412</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ichimura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kliks</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Visrutaratna</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ou</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Kalish</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>JA</given-names></name></person-group>: <article-title>Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>1994</year>;<volume>10</volume>:<fpage>263</fpage>&#x02013;<lpage>269</lpage><pub-id pub-id-type="pmid">8018386</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hemelaar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Elangovan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>J</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Global and regional molecular epidemiology of HIV-1, 1990&#x02013;2015: A systematic review, global survey, and trend analysis</article-title>. <source>Lancet Infect Dis</source>
<year>2019</year>;<volume>19</volume>:<fpage>143</fpage>&#x02013;<lpage>155</lpage><pub-id pub-id-type="pmid">30509777</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Angelis</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Albert</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mamais</surname><given-names>I</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Global dispersal pattern of HIV type 1 subtype CRF01_AE: A genetic trace of human mobility related to heterosexual sexual activities centralized in Southeast Asia</article-title>. <source>J Infect Dis</source>
<year>2015</year>;<volume>211</volume>:<fpage>1735</fpage>&#x02013;<lpage>1744</lpage><pub-id pub-id-type="pmid">25512631</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>He</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Hsi</surname><given-names>JH</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s</article-title>. <source>AIDS</source>
<year>2013</year>;<volume>27</volume>:<fpage>1793</fpage>&#x02013;<lpage>1802</lpage><pub-id pub-id-type="pmid">23807275</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Tracing the epidemic history of HIV-1 CRF01_AE clusters using near-complete genome sequences</article-title>. <source>Sci Rep</source>
<year>2017</year>;<volume>7</volume>:<fpage>4024</fpage><pub-id pub-id-type="pmid">28642469</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tee</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Hase</surname><given-names>S</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam</article-title>. <source>Virology</source>
<year>2009</year>;<volume>391</volume>:<fpage>51</fpage>&#x02013;<lpage>56</lpage><pub-id pub-id-type="pmid">19540543</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rodgers</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Vallari</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>B</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon</article-title>. <source>Virology</source>
<year>2017</year>;<volume>504</volume>:<fpage>141</fpage>&#x02013;<lpage>151</lpage><pub-id pub-id-type="pmid">28193549</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rodgers</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Vallari</surname><given-names>A</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Sensitive next-generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo</article-title>. <source>J Virol</source>
<year>2017</year>;<volume>91</volume>:<fpage>e01841</fpage>-<lpage>16</lpage><pub-id pub-id-type="pmid">28077647</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vidal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Mulanga</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bazepeo</surname><given-names>SE</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC)</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>2006</year>;<volume>22</volume>:<fpage>202</fpage>&#x02013;<lpage>206</lpage><pub-id pub-id-type="pmid">16478404</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Adawaye</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fokam</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kamangu</surname><given-names>E</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: Findings from a cross-sectional study</article-title>. <source>BMC Res Notes</source>
<year>2017</year>;<volume>10</volume>:<fpage>589</fpage><pub-id pub-id-type="pmid">29126456</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vidal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Koyalta</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>V</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>High genetic diversity of HIV-1 strains in Chad, West Central Africa</article-title>. <source>J Acquir Immune Defic Syndr</source>
<year>2003</year>;<volume>33</volume>:<fpage>239</fpage>&#x02013;<lpage>246</lpage><pub-id pub-id-type="pmid">12794561</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Niama</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Toure-Kane</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>N</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>HIV-1 subtypes and recombinants in the Republic of Congo</article-title>. <source>Infect Genet Evol</source>
<year>2006</year>;<volume>6</volume>:<fpage>337</fpage>&#x02013;<lpage>343</lpage><pub-id pub-id-type="pmid">16473564</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Niama</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Diop-Ndiaye</surname><given-names>H</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo</article-title>. <source>BMC Res Notes</source>
<year>2017</year>;<volume>10</volume>:<fpage>243</fpage><pub-id pub-id-type="pmid">28679441</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pircher</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Diafouka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Papuchon</surname><given-names>J</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>2012</year>;<volume>28</volume>:<fpage>1798</fpage>&#x02013;<lpage>1802</lpage><pub-id pub-id-type="pmid">22697883</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Marechal</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Jauvin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Selekon</surname><given-names>B</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Increasing HIV type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from Central African Republic: A 2005 study</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>2006</year>;<volume>22</volume>:<fpage>1036</fpage>&#x02013;<lpage>1044</lpage><pub-id pub-id-type="pmid">17067275</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brennan</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Bodelle</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Coffey</surname><given-names>R</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004</article-title>. <source>J Acquir Immune Defic Syndr</source>
<year>2008</year>;<volume>49</volume>:<fpage>432</fpage>&#x02013;<lpage>439</lpage><pub-id pub-id-type="pmid">18931623</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Achari</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Federman</surname><given-names>S</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Metagenomic sequencing with spiked primer enrichment (MSSPE) for viral diagnostics and genomic surveillance</article-title>. <source>Nat Microbiol</source>
<year>2019</year>;<volume>5</volume>:<fpage>443</fpage>&#x02013;<lpage>454</lpage></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pineda-Pena</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Faria</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Imbrechts</surname><given-names>S</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: Performance evaluation of the new REGA version 3 and seven other tools</article-title>. <source>Infect Genet Evol</source>
<year>2013</year>;<volume>19</volume>:<fpage>337</fpage>&#x02013;<lpage>348</lpage><pub-id pub-id-type="pmid">23660484</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schultz</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bulla</surname><given-names>I</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>jpHMM: Improving the reliability of recombination prediction in HIV-1</article-title>. <source>Nucleic Acids Res</source>
<year>2009</year>;<volume>37</volume>:<fpage>W647</fpage>&#x02013;<lpage>W651</lpage><pub-id pub-id-type="pmid">19443440</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Salminen</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Carr</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Burke</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>McCutchan</surname><given-names>FE</given-names></name></person-group>: <article-title>Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>1995</year>;<volume>11</volume>:<fpage>1423</fpage>&#x02013;<lpage>1425</lpage><pub-id pub-id-type="pmid">8573403</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stamatakis</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ludwig</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Meier</surname><given-names>H</given-names></name></person-group>: <article-title>RAxML-III: A fast program for maximum likelihood-based inference of large phylogenetic trees</article-title>. <source>Bioinformatics</source>
<year>2005</year>;<volume>21</volume>:<fpage>456</fpage>&#x02013;<lpage>463</lpage><pub-id pub-id-type="pmid">15608047</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kalyaanamoorthy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Minh</surname><given-names>BQ</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>TKF</given-names></name>, <name name-style="western"><surname>von Haeseler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jermiin</surname><given-names>LS</given-names></name></person-group>: <article-title>ModelFinder: Fast model selection for accurate phylogenetic estimates</article-title>. <source>Nat Methods</source>
<year>2017</year>;<volume>14</volume>:<fpage>587</fpage>&#x02013;<lpage>589</lpage><pub-id pub-id-type="pmid">28481363</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Felsenstein</surname><given-names>J.</given-names></name></person-group>
<article-title>Confidence limits on phylogenies: An approach using the bootstrap</article-title>. <source>Evolution</source>
<year>1985</year>;<volume>39</volume>:<fpage>783</fpage>&#x02013;<lpage>791</lpage><pub-id pub-id-type="pmid">28561359</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lemoine</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Domelevo Entfellner</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>E</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Renewing Felsenstein's phylogenetic bootstrap in the era of big data</article-title>. <source>Nature</source>
<year>2018</year>;<volume>556</volume>:<fpage>452</fpage>&#x02013;<lpage>456</lpage><pub-id pub-id-type="pmid">29670290</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hadfield</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Megill</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>SM</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Nextstrain: Real-time tracking of pathogen evolution</article-title>. <source>Bioinformatics</source>
<year>2018</year>;<volume>34</volume>:<fpage>4121</fpage>&#x02013;<lpage>4123</lpage><pub-id pub-id-type="pmid">29790939</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Katoh</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Standley</surname><given-names>DM</given-names></name></person-group>: <article-title>MAFFT multiple sequence alignment software version 7: Improvements in performance and usability</article-title>. <source>Mol Biol Evol</source>
<year>2013</year>;<volume>30</volume>:<fpage>772</fpage>&#x02013;<lpage>780</lpage><pub-id pub-id-type="pmid">23329690</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lanave</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Preparata</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Saccone</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Serio</surname><given-names>G</given-names></name></person-group>: <article-title>A new method for calculating evolutionary substitution rates</article-title>. <source>J Mol Evol</source>
<year>1984</year>;<volume>20</volume>:<fpage>86</fpage>&#x02013;<lpage>93</lpage><pub-id pub-id-type="pmid">6429346</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>To</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lycett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gascuel</surname><given-names>O</given-names></name></person-group>: <article-title>Fast dating using least-squares criteria and algorithms</article-title>. <source>Syst Biol</source>
<year>2016</year>;<volume>65</volume>:<fpage>82</fpage>&#x02013;<lpage>97</lpage><pub-id pub-id-type="pmid">26424727</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suchard</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Lemey</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Baele</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ayres</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Drummond</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name></person-group>: <article-title>Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10</article-title>. <source>Virus Evol</source>
<year>2018</year>;<volume>4</volume>:<fpage>vey016</fpage><pub-id pub-id-type="pmid">29942656</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="web">
<person-group person-group-type="author"><name name-style="western"><surname>Rambaut</surname><given-names>A.</given-names></name></person-group> FigTree. Available from <uri xlink:href="http://tree.bio.ed.ac.uk/software/figtree/">http://tree.bio.ed.ac.uk/software/figtree/</uri> (2018)</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Paradis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Claude</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Strimmer</surname><given-names>K</given-names></name></person-group>: <article-title>APE: Analyses of phylogenetics and evolution in R language</article-title>. <source>Bioinformatics</source>
<year>2004</year>;<volume>20</volume>:<fpage>289</fpage>&#x02013;<lpage>290</lpage><pub-id pub-id-type="pmid">14734327</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Max Carvalho</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pybus</surname><given-names>OG</given-names></name></person-group>: <article-title>Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen)</article-title>. <source>Virus Evol</source>
<year>2016</year>;<volume>2</volume>:<fpage>vew007</fpage><pub-id pub-id-type="pmid">27774300</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>LT</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>von Haeseler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Minh</surname><given-names>BQ</given-names></name></person-group>: <article-title>IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies</article-title>. <source>Mol Biol Evol</source>
<year>2015</year>;<volume>32</volume>:<fpage>268</fpage>&#x02013;<lpage>274</lpage><pub-id pub-id-type="pmid">25371430</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Drummond</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name></person-group>: <article-title>Relaxed phylogenetics and dating with confidence</article-title>. <source>PLoS Biol</source>
<year>2006</year>;<volume>4</volume>:<fpage>e88</fpage><pub-id pub-id-type="pmid">16683862</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pybus</surname><given-names>OG</given-names></name>, <name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Harvey</surname><given-names>PH</given-names></name></person-group>: <article-title>An integrated framework for the inference of viral population history from reconstructed genealogies</article-title>. <source>Genetics</source>
<year>2000</year>;<volume>155</volume>:<fpage>1429</fpage>&#x02013;<lpage>1437</lpage><pub-id pub-id-type="pmid">10880500</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Drummond</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Baele</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Suchard</surname><given-names>MA</given-names></name></person-group>: <article-title>Posterior summarisation in Bayesian phylogenetics using Tracer 1.7</article-title>. <source>Syst Biol</source>
<year>2018</year>;<volume>67</volume>:<fpage>901</fpage>&#x02013;<lpage>904</lpage><pub-id pub-id-type="pmid">29718447</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vidal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Frange</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chaix</surname><given-names>ML</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>2008</year>;<volume>24</volume>:<fpage>315</fpage>&#x02013;<lpage>321</lpage><pub-id pub-id-type="pmid">18257687</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Rasheed</surname><given-names>S</given-names></name></person-group>: <article-title>Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria</article-title>. <source>AIDS Res Hum Retroviruses</source>
<year>1996</year>;<volume>12</volume>:<fpage>1413</fpage>&#x02013;<lpage>1425</lpage><pub-id pub-id-type="pmid">8893049</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Khoja</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ojwang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Okinda</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Harania</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>S</given-names></name></person-group>: <article-title>Genetic analysis of HIV-1 subtypes in Nairobi, Kenya</article-title>. <source>PLoS One</source>
<year>2008</year>;<volume>3</volume>:<fpage>e3191</fpage><pub-id pub-id-type="pmid">18784834</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rhee</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Jordan</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Raizes</surname><given-names>E</given-names></name>, <etal><italic>et al.</italic></etal></person-group>: <article-title>HIV-1 drug resistance mutations: Potential applications for point-of-care genotypic resistance testing</article-title>. <source>PLoS One</source>
<year>2015</year>;<volume>10</volume>:<fpage>e0145772</fpage><pub-id pub-id-type="pmid">26717411</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Siraprapasiri</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ongwangdee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Benjarattanaporn</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Peerapatanapokin</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>M</given-names></name></person-group>: <article-title>The impact of Thailand's public health response to the HIV epidemic 1984&#x02013;2015: Understanding the ingredients of success</article-title>. <source>J Virus Erad</source>
<year>2016</year>;<volume>2</volume>(<issue>Suppl. 4</issue>):<fpage>7</fpage>&#x02013;<lpage>14</lpage><pub-id pub-id-type="pmid">28275444</pub-id></mixed-citation></ref></ref-list></back></article>